The past week has brought a steady flow of signals from major global regulators, offering a snapshot of how oversight is ...
Dutch clinical-stage cancer drug developer Merus, which is developing innovative, full-length multi-specific antibodies and ...
US genetic medicine company Sarepta Therapeutics has announced an update to the prescribing information for Elevidys ...